Product Code: ETC6186122 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neurointerventional devices market in Australia focuses on minimally invasive procedures for treating neurological conditions such as brain aneurysms, strokes, and arteriovenous malformations. The adoption of advanced neurointerventional devices, including stents, coils, and balloons, has transformed the treatment landscape. Australias highly developed healthcare infrastructure supports the growth of this market, with medical professionals increasingly opting for less invasive options to improve patient recovery times and reduce surgical risks.
The Australia neurointerventional devices market is expanding due to the increasing prevalence of cerebrovascular diseases such as strokes, aneurysms, and arteriovenous malformations. The adoption of minimally invasive techniques, which are less risky and offer faster recovery times compared to traditional surgical procedures, is a key driver. Technologies such as thrombectomy devices, embolization coils, and stents are increasingly being used in neurovascular procedures. Nevertheless, the market faces challenges such as the high cost of neurointerventional devices and the need for specialized training for medical professionals to handle these advanced tools effectively.
The Australia Neurointerventional Devices Market is challenged by the complex regulatory approval process, high device costs, and the technical expertise required for successful procedures. Limited access in remote areas also restricts broader market penetration.
With the increasing burden of stroke and cerebral aneurysms in Australia, the neurointerventional devices market is poised for growth. There is a strong demand for minimally invasive procedures using stents, catheters, and embolization devices. Investors can tap into opportunities by funding R&D in next-generation devices, partnering with hospitals for clinical trials, or acquiring innovative med-tech startups focused on neurovascular solutions.
The TGA mandates stringent device registration processes under the Australian Regulatory Guidelines for Medical Devices (ARGMD). The government also funds public hospitals through initiatives like the National Health Reform Agreement, supporting access to advanced neurointerventional procedures such as clot retrievals for stroke.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurointerventional Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurointerventional Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurointerventional Devices Market - Industry Life Cycle |
3.4 Australia Neurointerventional Devices Market - Porter's Five Forces |
3.5 Australia Neurointerventional Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Neurointerventional Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Neurointerventional Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neurointerventional Devices Market Trends |
6 Australia Neurointerventional Devices Market, By Types |
6.1 Australia Neurointerventional Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurointerventional Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Neurointerventional Devices Market Revenues & Volume, By Aneurysm Coiling & Embolization Devices, 2021- 2031F |
6.1.4 Australia Neurointerventional Devices Market Revenues & Volume, By Cerebral Balloon Angioplasty and Stenting Systems, 2021- 2031F |
6.1.5 Australia Neurointerventional Devices Market Revenues & Volume, By Neurothrombectomy Devices, 2021- 2031F |
6.1.6 Australia Neurointerventional Devices Market Revenues & Volume, By Other Devices, 2021- 2031F |
6.2 Australia Neurointerventional Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurointerventional Devices Market Revenues & Volume, By Ischemic Stroke, 2021- 2031F |
6.2.3 Australia Neurointerventional Devices Market Revenues & Volume, By Cerebral Aneurysms, 2021- 2031F |
6.2.4 Australia Neurointerventional Devices Market Revenues & Volume, By Arteriovenous Malformation and Fistulas, 2021- 2031F |
6.2.5 Australia Neurointerventional Devices Market Revenues & Volume, By Other Diseases, 2021- 2031F |
7 Australia Neurointerventional Devices Market Import-Export Trade Statistics |
7.1 Australia Neurointerventional Devices Market Export to Major Countries |
7.2 Australia Neurointerventional Devices Market Imports from Major Countries |
8 Australia Neurointerventional Devices Market Key Performance Indicators |
9 Australia Neurointerventional Devices Market - Opportunity Assessment |
9.1 Australia Neurointerventional Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Neurointerventional Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Neurointerventional Devices Market - Competitive Landscape |
10.1 Australia Neurointerventional Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurointerventional Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |